Free Trial
CVE:RX

BioSyent (RX) Stock Price, News & Analysis

BioSyent logo
C$11.40 -0.05 (-0.44%)
As of 08/8/2025 03:59 PM Eastern

About BioSyent Stock (CVE:RX)

Key Stats

Today's Range
C$11.38
C$11.40
50-Day Range
C$11.15
C$12.00
52-Week Range
C$9.20
C$12.13
Volume
634 shs
Average Volume
4,109 shs
Market Capitalization
C$130.39 million
P/E Ratio
18.50
Dividend Yield
1.58%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioSyent and its competitors with MarketBeat's FREE daily newsletter.

RX Stock News Headlines

Biosyent Inc. Stock Price History
BioSyent (CVE:RX) Has Announced A Dividend Of CA$0.05
National 'Stock Market Reset' Coming September 30 (New WH Order)
Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions of Americans at risk of blackouts and could lead to a crisis "many times worse than 2008" if not fixed.
BioSyent Inc. (RX.V)
See More Headlines

RX Stock Analysis - Frequently Asked Questions

BioSyent's stock was trading at C$11.00 at the beginning of 2025. Since then, RX stock has increased by 3.6% and is now trading at C$11.40.

BioSyent Inc. (CVE:RX) released its earnings results on Thursday, May, 25th. The company reported $0.06 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.08 by $0.02. The business earned $3.82 million during the quarter, compared to the consensus estimate of $4.80 million. BioSyent had a trailing twelve-month return on equity of 20.01% and a net margin of 20.60%.

Shares of RX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that BioSyent investors own include Aurora Cannabis (ACB), Astec Industries (ASTE), Bank of Nova Scotia (BNS), Carnival (CCL), Cisco Systems (CSCO), Devon Energy (DVN) and Ford Motor (F).

Company Calendar

Last Earnings
5/25/2017
Today
8/09/2025

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
CVE:RX
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C$0.62
Trailing P/E Ratio
18.50
Forward P/E Ratio
16.42
P/E Growth
N/A
Net Income
C$7.02 million
Net Margins
20.60%
Pretax Margin
N/A
Return on Equity
20.01%
Return on Assets
12.86%

Debt

Debt-to-Equity Ratio
2.90
Current Ratio
3.92
Quick Ratio
6.91

Sales & Book Value

Annual Sales
C$34.06 million
Price / Sales
3.83
Cash Flow
C$3.71 per share
Price / Cash Flow
3.07
Book Value
C$3.22 per share
Price / Book
3.54

Miscellaneous

Outstanding Shares
11,437,447
Free Float
N/A
Market Cap
C$130.39 million
Optionable
Not Optionable
Beta
0.93
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (CVE:RX) was last updated on 8/10/2025 by MarketBeat.com Staff
From Our Partners